ResearcherClinical DevelopmentNo recent work listed

Joyce Antal

Provisional: name at one institution (moderate confidence)As of 9 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Papers: 0
Trials: 2
Grants: 0
Collaborators: 0

Papers, trials and grants by year

2021: 1 trial · 2022: none · 2023: 1 trial

Trials 2

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations Study director NCT05907304 ↗
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies Study director NCT05039177 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.